- Latest available (Revised)
- Original (As adopted by EU)
Commission Implementing Decision of 31 July 2014 authorising laboratories in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2014) 5352) (Text with EEA relevance) (2014/514/EU)
You are here:
- Decisions originating from the EU
- 2014 No. 514
- Whole Decision
- Previous
- Next
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
Opening Options
More Resources
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
This item of legislation originated from the EU
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Changes over time for: Commission Implementing Decision of 31 July 2014 authorising laboratories in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2014) 5352) (Text with EEA relevance) (2014/514/EU)
Changes to legislation:
This version of this Decision was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Commission Implementing Decision
of 31 July 2014
authorising laboratories in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines
(notified under document C(2014) 5352)
(Text with EEA relevance)
(2014/514/EU)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Decision 2000/258/EC of 20 March 2000 designating a specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines(1), and in particular Article 3(2) thereof,
Whereas:
(1) Decision 2000/258/EC designates the Agence française de sécurité sanitaire des aliments (AFSSA) in Nancy, France (integrated since 1 July 2010 into the Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail, ANSES), as the specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines.
(2) That Decision provides that the ANSES is to document the appraisal of laboratories in third countries that have applied to carry out serological tests to monitor the effectiveness of rabies vaccines.
(3) The competent authority of the Republic of Korea has submitted an application for approval of the laboratory KBNP, INC in Sinam-myeon which is supported by a favourable appraisal report established for that laboratory by the ANSES dated 16 September 2013.
(4) Following the unfavourable appraisal report established by the ANSES dated 16 September 2013, the authorisation granted on 1 March 2011 in accordance with Decision 2000/258/EC to the laboratory Komipharm International Co. Ltd in Siheung-si has been withdrawn in accordance with Commission Decision 2010/436/EU(2).
(5) The competent authority of the Republic of Korea has submitted an application for re-approval of the laboratory Komipharm International Co. Ltd in Siheung-si which is supported by a favourable appraisal report established for that laboratory by the ANSES dated 24 April 2014.
(6) Those laboratories should therefore be authorised to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets.
(7) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION:
Article 1U.K.
In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratories are authorised to perform the serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets:
(a)
KBNP, INC
235-9, Chusa-ro, Sinam-myeon
Yesan-gun, Chungcheongnam-do
Republic of Korea
(b)
Komipharm International Co. Ltd
17 Gyeongje-ro,
Siheung-si, Gyeonggi-do,
429-848
Republic of Korea
Article 2U.K.
This Decision shall apply from 15 August 2014.
Article 3U.K.
This Decision is addressed to the Member States.
Done at Brussels, 31 July 2014.
For the Commission
Tonio Borg
Member of the Commission
(2)
Commission Decision 2010/436/EU of 9 August 2010 implementing Council Decision 2000/258/EC as regards proficiency tests for the purposes of maintaining authorisations of laboratories to carry out serological tests to monitor the effectiveness of rabies vaccines (OJ L 209, 10.8.2010, p. 19).
Options/Help
Print Options
PrintThe Whole Decision
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the EU Official Journal
- lists of changes made by and/or affecting this legislation item
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.